pemafibrate
Kowa Pharmaceuticals
[]
#prominent trial: pemafibrate with reduction in triglycerides, v ldl-c, remnant cholesterol, and apoc3 but no difference in cv events. other beneficial effects observed in nafld but need more study, more to come! 
Preventive Cardiologist @DukeHeartCenter | Assistant Professor | Alum of @ClevelandClinic @HopkinsMedicine | Father and Husband | Tweets are my own